This appeal arises from a final judgment dismissing with prejudice the negligence claims in Karan Oleckna’s
In May 2009, Steven Porter, now deceased, began treatment with Dr. Owen R. Hunt, who diagnosed him with “stress syndrome” and prescribed Xanax (Alprazo-lam) and Hydrocodone/Acetaminophen or Oxycodone/Acetaminophen.
Oleckna brought negligence claims against Pharmacy,
Pharmacy filed a motion to dismiss, arguing that based on McLeod v. W.S. Merrell Co., Division of Richardson-Merrell, Inc.,
As indicated in the Order Granting the Motion to Dismiss filed by the Defendant, Daytona Discount Pharmacy, Inc., directed to the Plaintiffs original complaint, there appears to be a conflict amongst the district courts as to what constitutes a viable cause of action against a prescribing pharmacist. The Plaintiff relies on Robert Powers v. Shirin H. Thobhani, M.D.,903 So.2d 275 (Fla. 4th DCA 2005). The Defendant relies upon the Estate of Edna Marie Sharp v. Omnicare, Inc.,879 So.2d 34 (Fla. 5th DCA 2004). The 5th District case follows the Supreme Court listed standard for a cause of action set forth in McLeod v. W.S. Merrell, Co.,174 So.2d 736 (Fla.1965). Apparently the conflict has not been recognized by the Florida Supreme Court.
In this particular case a careful reading of Count II and III, directed to the druggist and his pharmacy, have failed to allege a factual basis that would support a violation of the duty of care which has been severely limited in the McLeod case. As a result this court has concluded that the Plaintiff has failed to allege a recognizable cause of action against the druggist or the pharmacy in the Amended Complaint and further that there are no additional allegations that could be offered as subsequent amendments to change the outcome of this decision.
We conclude that our decision in Estate of Sharp is not controlling. As a result, the trial court erred in dismissing the negligence claims against Pharmacy.
The issue presented is whether Pharmacy owed a legal duty to Mr. Porter, which would support a negligence claim. This is a question of law for this Court to determine. Estate of Johnson ex rel. Johnson v. Badger Acquisition of Tampa LLC,
A pharmacy owes a customer a duty of reasonable care. Pharmacists are required to exercise that degree of care that an ordinarily prudent pharmacist would under the same or similar circumstances. Marjorie A. Shields, Annotation, Exemplary or Punitive Damages for Pharmacist’s Wrongful Conduct in Preparing or Dispensing Medical Prescription — Cases Not Under Consumer Product Safety Act,
In McLeod, a breach of warranty case, the issue before the Florida Supreme Court was whether a pharmacy could be held strictly liable for its failure to warn a customer of the possible dangers of using the drug it dispensed in accordance with a doctor’s prescription.
Florida decisions since McLeod provide guidance. In Dee v. Wal-Mart Stores, Inc.,
The Fourth District Court of Appeal clarified McLeod further in Powers v. Thobhani,
We agree with Powers and hold that a pharmacist’s duty to use due and proper care in filling a prescription extends beyond simply following the prescribing physician’s directions. In the instant case, accepting the allegations of the amended complaint as true, Pharmacy filled, without question, numerous prescriptions that were so close together that Pharmacy should have been put on notice that Mr. Porter was getting too many pills within too short a period — similar to the pharmacies in Powers. We refuse to interpret a pharmacist’s duty to use “due and proper care in filling the prescription” as being satisfied by “robotic compliance” with the instructions of the prescribing physician. See Arrington v. Walgreen Co.,
Our decision in Estate of Sharp does not conflict with Powers. See also Your Druggist, Inc. v. Powers,
The allegations in this case are substantially different than those described in Estate of Sharp. Unlike here, where Pharmacy interacted directly with Mr. Porter, in Estate of Sharp, the consultant pharmacy had no interaction with the decedent, but instead, dealt only with the nursing home. Accord Badger Acquisition,
REVERSED and REMANDED.
Notes
. Ms. Oleckna is the personal representative of the Estate of Steven Porter.
. Hydrocodone is a Schedule II and III narcotic, and a controlled substance. Oxycodone is a Schedule II narcotic and controlled substance. Alprazolam is a Schedule IV controlled substance. See § 893.03, Fla. Stat. (2010). "A substance listed in Schedule II has ‘a high potential for abuse and has a currently accepted but severely restricted medical use in treatment in the United States, and abuse of the substance may lead to severe psychological or physical dependence.' ” Hayes v. State,
. Oleckna also brought a negligence action against Dr. Hunt, who settled his case.
. The Florida pharmaceutical regulatory statutes and administrative codes do not create a private cause of action against pharmacists. See Badger Acquisition,
[a]s an element of dispensing, the pharmacist shall, prior to the actual physical transfer, interpret and assess the prescription order for potential adverse reactions, interactions, and dosage regimen she or he deems appropriate in the exercise of her or his professional judgment, and the pharmacist shall certify that the medicinal drug called for by the prescription is ready for transfer. The pharmacist shall also provide counseling on proper drug usage, either orally or in writing, if in the exercise of her or his professional judgment counseling is necessary.
See also Fla. Admin. Code R. 64B16-27.300, 64B 16-27.820. Florida pharmacists are specifically charged with general knowledge of prescription medication and the risks presented by taking particular prescription drugs, such that they should be able to evaluate and explain the operative risks of taking a medication or series of medications. In essence, a strong policy basis already exists supporting a pharmacist’s duty to warn customers of the inherent risks in filling repeated and unreasonable prescriptions with potentially fatal consequences. Powers,
